Cartesian Therapeutics, Inc.
Ticker: 1453687
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY25 | Q1 FY25 | Q2 FY24 | Q2 FY24 | Q1 FY24 | Q3 FY23 | Q3 FY23 | Q2 FY23 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 0.40+0.0% | 0.40-98.8% | 33.27+0.0% | 33.27+469.7% | 5.84-10.8% | 6.55+0.0% | 6.55+24.8% | 5.25 |
| Total Income | 0.40+0.0% | 0.40-98.8% | 33.27+0.0% | 33.27+469.7% | 5.84-10.8% | 6.55+0.0% | 6.55+24.8% | 5.25 |
| EXPENSES | ||||||||
| Expenditure | 22.29+0.0% | 22.29+14.2% | 19.51+0.0% | 19.51+1.7% | 19.19-2.2% | 19.62+0.0% | 19.62-17.9% | 23.89 |
| PROFIT | ||||||||
| PBT | — | — | — | — | — | — | -9.00 | — |
| Net Profit | -17.71+0.0% | -17.71-228.0% | 13.84+0.0% | 13.84+124.4% | -56.82-531.3% | -9.00+0.0% | -9.00+21.0% | -11.39 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00%-141.35pp | 41.35% | 41.35%+141.35pp | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00%-141.58pp | 41.59% | 41.59%+141.58pp | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.68+0.0% | -0.68-217.2% | 0.58+0.0% | 0.58+105.5% | -10.50-503.4% | -1.74-2800.0% | -0.06+14.3% | -0.07 |
Corporate Events
Board MeetingRNAC
202612Jun
Board Meeting
2026 Annual Meeting of Stockholders to vote on the election …
SEC Filing ↗ Board MeetingRNAC
202622May
Board Meeting
Cartesian Therapeutics, Inc. entered into a Loan and Securit…
SEC Filing ↗